Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
The European Business Association has been working in Ukraine since 1999. The purpose of existence is ensuring the development of companies and giving them opportunities to influence the investment climate:…